Lawrence Kenyon was appointed President and CEO of Oncobiologics, Inc. Based in Cranbury, United States.
Lawrence Kenyon was appointed President and CEO of Oncobiologics, Inc. on August 2, 2018, having previously served as the company's CFO and Corporate Secretary since September 2015. Oncobiologics is a clinical-stage biopharmaceutical company focused on developing and commercializing complex monoclonal antibody therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library